Format

Send to

Choose Destination
Mol Ther. 2018 Jan 3;26(1):14-16. doi: 10.1016/j.ymthe.2017.12.007. Epub 2017 Dec 21.

Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy.

Author information

1
Department of Gene Therapy & Regenerative Medicine, Free University of Brussels (VUB), Faculty of Medicine & Pharmacy, Brussels, Belgium; Center for Molecular & Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. Electronic address: thierry.vandendriessche@vub.ac.be.
2
Department of Gene Therapy & Regenerative Medicine, Free University of Brussels (VUB), Faculty of Medicine & Pharmacy, Brussels, Belgium; Center for Molecular & Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium. Electronic address: marinee.chuah@vub.ac.be.
PMID:
29274719
PMCID:
PMC5763158
DOI:
10.1016/j.ymthe.2017.12.007
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center